AstraZeneca vaccine trial restarts in Japan
Trials in the UK, Brazil, SA and India have already restarted, but US trials remain paused as regulators widen their probe
02 October 2020 - 11:54
Bengaluru — Clinical trials of AstraZeneca and Oxford University's experimental Covid-19 vaccine have resumed in Japan, almost a month after being put on hold due to an illness of a British volunteer, while discussions with US authorities continue.
The British drugmaker said on Friday the early-to-mid-stage trial for the vaccine against the novel coronavirus resumed in Japan after consultations with the national health regulator, the Japanese Pharmaceuticals and Medical Devices Agency...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.